Khosrow Adeli Selected Research

Glucose (Dextrose)

6/2021	POCT: An Inherently Ideal Tool in Pediatric Laboratory Medicine.
1/2018	GLP-2 Dysregulates Hepatic Lipoprotein Metabolism, Inducing Fatty Liver and VLDL Overproduction in Male Hamsters and Mice.
1/2017	Duration of Fasting, Serum Lipids, and Metabolic Profile in Early Childhood.
8/2016	Clinical impact of improved point-of-care glucose monitoring in neonatal intensive care using Nova StatStrip: Evidence for improved accuracy, better sensitivity, and reduced test utilization.
1/2013	AMP-activated protein kinase and ATP-citrate lyase are two distinct molecular targets for ETC-1002, a novel small molecule regulator of lipid and carbohydrate metabolism.
5/2012	Ezetimibe ameliorates intestinal chylomicron overproduction and improves glucose tolerance in a diet-induced hamster model of insulin resistance.
8/2011	Delayed ghrelin suppression following oral glucose tolerance test in children and adolescents with hypothalamic injury secondary to craniopharyngioma compared with obese controls.
1/2011	C-reactive protein impairs hepatic insulin sensitivity and insulin signaling in rats: role of mitogen-activated protein kinases.
9/2009	Hepatic insulin resistance, metabolic syndrome and cardiovascular disease.
9/2006	The relationship between homeostasis model assessment and cardiovascular risk factors in Iranian subjects with normal fasting glucose and normal glucose tolerance.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Khosrow Adeli Research Topics

Disease

59	Insulin Resistance 11/2022 - 01/2002
43	Dyslipidemias (Dyslipidemia) 02/2024 - 03/2002
20	Metabolic Syndrome (Dysmetabolic Syndrome X) 03/2017 - 09/2003
16	Obesity 01/2022 - 06/2007
16	Type 2 Diabetes Mellitus (MODY) 01/2022 - 03/2002
14	Inflammation (Inflammations) 10/2023 - 03/2008
13	Cardiovascular Diseases (Cardiovascular Disease) 11/2022 - 06/2006
13	Hypertriglyceridemia 09/2015 - 03/2002
9	Hyperlipidemias (Hyperlipidemia) 01/2020 - 07/2002
8	COVID-19 01/2022 - 01/2020
7	Neoplasms (Cancer) 01/2023 - 12/2008
6	Hyperinsulinism (Hyperinsulinemia) 01/2020 - 04/2002
5	Heart Failure 01/2023 - 02/2011
5	Fatty Liver 01/2018 - 12/2008
5	Hyperglycemia 01/2017 - 04/2002
5	Atherosclerosis 06/2012 - 06/2006
5	Hepatocellular Carcinoma (Hepatoma) 10/2008 - 02/2004
3	Myocarditis (Carditis) 10/2023 - 01/2021
3	Myocardial Infarction 01/2023 - 01/2018
3	Hemorrhage 02/2020 - 05/2005
3	Overweight 01/2020 - 11/2007
3	Glucose Intolerance 12/2017 - 08/2009
3	Weight Gain 09/2015 - 12/2004
3	Body Weight (Weight, Body) 12/2014 - 11/2009
3	Hypercholesterolemia 05/2012 - 10/2006
2	Congenital Heart Defects (Congenital Heart Defect) 01/2023 - 01/2021
2	Acute Kidney Injury (Acute Renal Failure) 01/2021 - 02/2020
2	Non-alcoholic Fatty Liver Disease 01/2019 - 01/2018
2	Metabolic Diseases (Metabolic Disease) 01/2019 - 09/2015
2	Hyperlipoproteinemia Type II (Familial Hypercholesterolemia) 01/2018 - 05/2012
2	Diabetic Nephropathies (Diabetic Nephropathy) 06/2014 - 03/2011
2	Lecithin Cholesterol Acyltransferase Deficiency (Lecithin:Cholesterol Acyltransferase Deficiency) 06/2012 - 08/2007
2	Craniopharyngioma (Craniopharyngiomas) 08/2011 - 05/2010

Drug/Important Bio-Agent (IBA)

55	Insulin (Novolin)FDA Link 01/2022 - 01/2002
32	Lipoproteins (Lipoprotein)IBA 01/2020 - 03/2002
30	LipidsIBA 11/2022 - 11/2004
29	FructoseIBA 11/2020 - 01/2002
15	Triglycerides (Triacylglycerol)IBA 01/2021 - 03/2002
13	Biomarkers (Surrogate Marker)IBA 01/2023 - 06/2006
13	Glucose (Dextrose)FDA LinkGeneric 06/2021 - 03/2002
13	Proteins (Proteins, Gene)FDA Link 01/2018 - 04/2002
13	Apolipoproteins B (ApoB)IBA 08/2011 - 01/2002
11	VLDL LipoproteinsIBA 01/2018 - 01/2002
10	ChylomicronsIBA 10/2017 - 02/2007
10	ApolipoproteinsIBA 05/2010 - 01/2003
9	Glucagon-Like Peptide 1 (GLP 1)IBA 11/2022 - 02/2013
8	CholesterolIBA 01/2021 - 08/2009
7	Apolipoprotein B-48IBA 10/2015 - 08/2002
6	AntigensIBA 01/2023 - 12/2014
5	TroponinIBA 10/2023 - 01/2021
5	Tyrosine (L-Tyrosine)FDA Link 03/2010 - 04/2002
5	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 05/2008 - 03/2002
4	Natriuretic PeptidesIBA 01/2023 - 02/2011
4	C-Reactive ProteinIBA 01/2022 - 03/2007
4	Messenger RNA (mRNA)IBA 12/2017 - 08/2009
4	HDL LipoproteinsIBA 09/2012 - 03/2002
4	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 05/2010 - 02/2007
4	HDL CholesterolIBA 08/2007 - 03/2002
4	Nonesterified Fatty Acids (NEFA)IBA 06/2006 - 04/2002
3	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2023 - 02/2011
3	Peptides (Polypeptides)IBA 01/2023 - 12/2014
3	EnzymesIBA 01/2022 - 01/2017
3	Dietary Fats (Dietary Fat)IBA 01/2020 - 08/2009
3	LDL Receptors (LDL Receptor)IBA 01/2018 - 09/2009
3	IncretinsIBA 07/2015 - 02/2012
3	Fatty Acids (Saturated Fatty Acids)IBA 05/2015 - 05/2005
3	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 06/2014 - 03/2006
3	LeptinIBA 11/2010 - 11/2008
3	CytokinesIBA 09/2009 - 02/2007
3	Insulin ReceptorIBA 08/2009 - 04/2002
3	Non-Receptor Type 1 Protein Tyrosine PhosphataseIBA 08/2009 - 01/2002
3	Rosiglitazone (Avandia)FDA Link 01/2005 - 08/2002
2	Hormones (Hormone)IBA 01/2023 - 12/2014
2	Estradiol (Delestrogen)FDA LinkGeneric 01/2023 - 01/2018
2	trans-crotonin (CTN)IBA 01/2023 - 01/2021
2	pro-brain natriuretic peptide (1-76)IBA 01/2023 - 01/2021
2	Ferritins (Ferritin)IBA 01/2022 - 01/2018
2	AntibodiesIBA 12/2021 - 10/2020
2	Immunoglobulin G (IgG)IBA 12/2021 - 01/2018
2	Bile Acids and Salts (Bile Acids)IBA 01/2020 - 01/2020
2	Glucagon-Like Peptide-1 ReceptorIBA 01/2020 - 12/2014
2	Exenatide (Byetta)FDA Link 01/2020 - 12/2014
2	Glucagon-Like Peptide-2 ReceptorIBA 01/2019 - 01/2018
2	Glucagon-Like Peptides (Enteroglucagon)IBA 01/2019 - 07/2015
2	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2019 - 11/2010
2	Apolipoproteins AIBA 01/2018 - 11/2007
2	Testosterone (Sustanon)FDA Link 01/2018 - 07/2014
2	Prostate-Specific Antigen (Semenogelase)IBA 01/2018 - 12/2014
2	VitaminsIBA 01/2018 - 06/2014
2	Sterol Regulatory Element Binding Protein 1IBA 12/2017 - 05/2013
2	Serotonin (5 Hydroxytryptamine)IBA 01/2017 - 08/2013
2	CarbohydratesIBA 12/2014 - 06/2006
2	SterolsIBA 01/2013 - 05/2006
2	LDL Lipoproteins (beta Lipoproteins)IBA 09/2012 - 03/2002
2	GhrelinIBA 08/2011 - 11/2008
2	Lactic Acid (Lactate)FDA LinkGeneric 01/2011 - 04/2010
2	Ascorbic Acid (Vitamin C)FDA LinkGeneric 12/2010 - 05/2005
2	AdipokinesIBA 05/2010 - 09/2009

Therapy/Procedure

10	Therapeutics 10/2022 - 04/2006
2	Personal Protective Equipment 12/2020 - 01/2020